The Defendant’s Use of Medical Equipment May Have Been Unhygienic, But It Didn’t Amount to an FCA Violation
The relator alleged the defendant engaged in a fraudulent scheme to encourage customers to reuse a monitoring system on patients contrary to its Food and Drug Administration (FDA) label.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.